UniProt ID | LRRF1_HUMAN | |
---|---|---|
UniProt AC | Q32MZ4 | |
Protein Name | Leucine-rich repeat flightless-interacting protein 1 | |
Gene Name | LRRFIP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 808 | |
Subcellular Localization | Nucleus. Cytoplasm. | |
Protein Description | Transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. May control smooth muscle cells proliferation following artery injury through PDGFA repression. May also bind double-stranded RNA. Positively regulates Toll-like receptor (TLR) signaling in response to agonist probably by competing with the negative FLII regulator for MYD88-binding.. | |
Protein Sequence | MTSPAAAQSREIDCLSPEAQKLAEARLAAKRAARAEAREIRMKELERQQKEEDSERYSRRSRRNTSASDEDERMSVGSRGSLRVEERPEKDFTEKGSRNMPGLSAATLASLGGTSSRRGSGDTSISIDTEASIREIKELNELKDQIQDVEGKYMQGLKEMKDSLAEVEEKYKKAMVSNAQLDNEKTNFMYQVDTLKDMLLELEEQLAESRRQYEEKNKEFEREKHAHSILQFQFAEVKEALKQREEMLEKHGIILNSEIATNGETSDTLNNVGYQGPTKMTKEELNALKSTGDGTLGRASEVEVKNEIVANVGKREILHNTEKEQHTEDTVKDCVDIEVFPAGENTEDQKSSEDTAPFLGTLAGATYEEQVQSQILESSSLPENTVQVESNEVMGAPDDRTRTPLEPSNCWSDLDGGNHTENVGEAAVTQVEEQAGTVASCPLGHSDDTVYHDDKCMVEVPQELETSTGHSLEKEFTNQEAAEPKEVPAHSTEVGRDHNEEEGEETGLRDEKPIKTEVPGSPAGTEGNCQEATGPSTVDTQNEPLDMKEPDEEKSDQQGEALDSSQKKTKNKKKKNKKKKSPVPVETLKDVKKELTYQNTDLSEIKEEEQVKSTDRKSAVEAQNEVTENPKQKIAAESSENVDCPENPKIKLDGKLDQEGDDVQTAAEEVLADGDTLDFEDDTVQSSGPRAGGEELDEGVAKDNAKIDGATQSSPAEPKSEDADRCTLPEHESPSQDISDACEAESTERCEMSEHPSQTVRKALDSNSLENDDLSAPGREPGHFNPESREDTRGGNEKGKSKEDCTMS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MTSPAAAQS ------CCCHHHHHC | 43.34 | 20068231 | |
2 | Phosphorylation | ------MTSPAAAQS ------CCCHHHHHC | 43.34 | 29255136 | |
2 (in isoform 2) | Acetylation | - | 43.34 | - | |
2 (in isoform 2) | Phosphorylation | - | 43.34 | - | |
3 | Phosphorylation | -----MTSPAAAQSR -----CCCHHHHHCC | 15.96 | 29255136 | |
3 (in isoform 2) | Phosphorylation | - | 15.96 | - | |
5 (in isoform 4) | Phosphorylation | - | 18.39 | 28348404 | |
8 (in isoform 4) | Phosphorylation | - | 37.99 | 28348404 | |
9 | Phosphorylation | TSPAAAQSREIDCLS CCHHHHHCCCCCCCC | 27.44 | 26074081 | |
14 | Carbamidation | AQSREIDCLSPEAQK HHCCCCCCCCHHHHH | 5.07 | 17322306 | |
16 | Phosphorylation | SREIDCLSPEAQKLA CCCCCCCCHHHHHHH | 27.33 | 29255136 | |
16 (in isoform 2) | Phosphorylation | - | 27.33 | 24719451 | |
20 (in isoform 4) | Phosphorylation | - | 39.37 | 28348404 | |
21 | Ubiquitination | CLSPEAQKLAEARLA CCCHHHHHHHHHHHH | 57.63 | - | |
57 | Phosphorylation | KEEDSERYSRRSRRN HHHHHHHHHHHHHCC | 11.50 | 28258704 | |
58 | Phosphorylation | EEDSERYSRRSRRNT HHHHHHHHHHHHCCC | 27.69 | 28258704 | |
65 | Phosphorylation | SRRSRRNTSASDEDE HHHHHCCCCCCCHHH | 24.69 | 25159151 | |
66 | Phosphorylation | RRSRRNTSASDEDER HHHHCCCCCCCHHHH | 29.35 | 25159151 | |
66 (in isoform 2) | Phosphorylation | - | 29.35 | 24719451 | |
68 | Phosphorylation | SRRNTSASDEDERMS HHCCCCCCCHHHHCC | 41.10 | 28355574 | |
68 (in isoform 2) | Phosphorylation | - | 41.10 | 24719451 | |
75 | Phosphorylation | SDEDERMSVGSRGSL CCHHHHCCCCCCCCC | 29.55 | 30108239 | |
78 | Phosphorylation | DERMSVGSRGSLRVE HHHCCCCCCCCCCCC | 31.17 | 28450419 | |
81 | Phosphorylation | MSVGSRGSLRVEERP CCCCCCCCCCCCCCC | 16.34 | 27251275 | |
88 (in isoform 3) | Phosphorylation | - | 57.16 | 28258704 | |
90 (in isoform 4) | Phosphorylation | - | 61.91 | - | |
91 (in isoform 3) | Phosphorylation | - | 54.78 | 25849741 | |
92 (in isoform 3) | Phosphorylation | - | 16.40 | 28258704 | |
97 | Phosphorylation | KDFTEKGSRNMPGLS CCCCCCCCCCCCCCC | 31.39 | 26074081 | |
97 (in isoform 4) | Phosphorylation | - | 31.39 | 25159151 | |
98 (in isoform 4) | Phosphorylation | - | 52.73 | 29507054 | |
100 | Sulfoxidation | TEKGSRNMPGLSAAT CCCCCCCCCCCCHHH | 2.43 | 21406390 | |
104 | Phosphorylation | SRNMPGLSAATLASL CCCCCCCCHHHHHHC | 23.05 | 23927012 | |
107 | Phosphorylation | MPGLSAATLASLGGT CCCCCHHHHHHCCCC | 23.67 | 29255136 | |
107 (in isoform 2) | Phosphorylation | - | 23.67 | 24719451 | |
110 | Phosphorylation | LSAATLASLGGTSSR CCHHHHHHCCCCCCC | 30.57 | 29255136 | |
110 (in isoform 2) | Phosphorylation | - | 30.57 | 24719451 | |
114 | Phosphorylation | TLASLGGTSSRRGSG HHHHCCCCCCCCCCC | 23.02 | 29255136 | |
114 (in isoform 2) | Phosphorylation | - | 23.02 | 21406692 | |
115 | Phosphorylation | LASLGGTSSRRGSGD HHHCCCCCCCCCCCC | 25.73 | 29255136 | |
115 (in isoform 2) | Phosphorylation | - | 25.73 | 21406692 | |
116 | Phosphorylation | ASLGGTSSRRGSGDT HHCCCCCCCCCCCCC | 26.32 | 29255136 | |
116 (in isoform 2) | Phosphorylation | - | 26.32 | - | |
120 | Phosphorylation | GTSSRRGSGDTSISI CCCCCCCCCCCCEEE | 31.51 | 19664994 | |
120 (in isoform 2) | Phosphorylation | - | 31.51 | 24719451 | |
123 | Phosphorylation | SRRGSGDTSISIDTE CCCCCCCCCEEECCH | 31.33 | 25159151 | |
123 (in isoform 2) | Phosphorylation | - | 31.33 | 25849741 | |
124 | Phosphorylation | RRGSGDTSISIDTEA CCCCCCCCEEECCHH | 21.05 | 25159151 | |
124 (in isoform 2) | Phosphorylation | - | 21.05 | 28258704 | |
126 | Phosphorylation | GSGDTSISIDTEASI CCCCCCEEECCHHHH | 17.74 | 30278072 | |
126 (in isoform 2) | Phosphorylation | - | 17.74 | - | |
129 | Phosphorylation | DTSISIDTEASIREI CCCEEECCHHHHHHH | 31.61 | 23927012 | |
132 | Phosphorylation | ISIDTEASIREIKEL EEECCHHHHHHHHHH | 18.88 | 23663014 | |
139 (in isoform 4) | Phosphorylation | - | 5.25 | 30183078 | |
141 (in isoform 4) | Phosphorylation | - | 70.58 | 30183078 | |
170 | Ubiquitination | SLAEVEEKYKKAMVS HHHHHHHHHHHHHHH | 49.19 | - | |
173 | Ubiquitination | EVEEKYKKAMVSNAQ HHHHHHHHHHHHCCC | 38.33 | - | |
175 | Sulfoxidation | EEKYKKAMVSNAQLD HHHHHHHHHHCCCCC | 4.69 | 21406390 | |
185 | Trimethylation | NAQLDNEKTNFMYQV CCCCCCCCCCCHHHH | 55.83 | - | |
185 | Methylation | NAQLDNEKTNFMYQV CCCCCCCCCCCHHHH | 55.83 | - | |
187 (in isoform 4) | Phosphorylation | - | 30.65 | 26437602 | |
197 (in isoform 4) | Phosphorylation | - | 35.75 | 26437602 | |
198 | Sulfoxidation | QVDTLKDMLLELEEQ HHHHHHHHHHHHHHH | 4.38 | 30846556 | |
204 (in isoform 4) | Phosphorylation | - | 64.62 | 22468782 | |
205 (in isoform 4) | Phosphorylation | - | 36.28 | 26437602 | |
209 (in isoform 4) | Phosphorylation | - | 27.44 | 28387310 | |
228 | Phosphorylation | EREKHAHSILQFQFA HHHHHHHHHHHHHHH | 26.27 | 27251275 | |
271 (in isoform 2) | Phosphorylation | - | 31.53 | - | |
280 | Sulfoxidation | GYQGPTKMTKEELNA CCCCCCCCCHHHHHH | 7.72 | 21406390 | |
289 | Ubiquitination | KEELNALKSTGDGTL HHHHHHHHHCCCCCC | 43.49 | - | |
290 | Phosphorylation | EELNALKSTGDGTLG HHHHHHHHCCCCCCC | 38.17 | 29214152 | |
291 | Phosphorylation | ELNALKSTGDGTLGR HHHHHHHCCCCCCCC | 37.39 | 29214152 | |
295 | Phosphorylation | LKSTGDGTLGRASEV HHHCCCCCCCCCCEE | 30.68 | 25159151 | |
300 | Phosphorylation | DGTLGRASEVEVKNE CCCCCCCCEEEECHH | 40.59 | 28355574 | |
305 | Sumoylation | RASEVEVKNEIVANV CCCEEEECHHHEEEC | 35.04 | 25114211 | |
314 | Acetylation | EIVANVGKREILHNT HHEEECCHHHHHCCC | 42.44 | 25953088 | |
314 | Ubiquitination | EIVANVGKREILHNT HHEEECCHHHHHCCC | 42.44 | - | |
321 | Phosphorylation | KREILHNTEKEQHTE HHHHHCCCCCCCCCC | 37.37 | 29514088 | |
323 | 2-Hydroxyisobutyrylation | EILHNTEKEQHTEDT HHHCCCCCCCCCCCH | 61.71 | - | |
366 | Phosphorylation | LGTLAGATYEEQVQS HHHHCCCCHHHHHHH | 30.46 | 27251275 | |
367 | Phosphorylation | GTLAGATYEEQVQSQ HHHCCCCHHHHHHHH | 19.55 | 27251275 | |
373 | Phosphorylation | TYEEQVQSQILESSS CHHHHHHHHHHHCCC | 21.97 | 27251275 | |
378 | Phosphorylation | VQSQILESSSLPENT HHHHHHHCCCCCCCE | 23.06 | 27251275 | |
379 | Phosphorylation | QSQILESSSLPENTV HHHHHHCCCCCCCEE | 26.90 | 27251275 | |
380 | Phosphorylation | SQILESSSLPENTVQ HHHHHCCCCCCCEEE | 58.17 | 27251275 | |
394 (in isoform 4) | Phosphorylation | - | 2.86 | 20068231 | |
399 (in isoform 4) | Phosphorylation | - | 53.44 | 20068231 | |
401 | Phosphorylation | MGAPDDRTRTPLEPS CCCCCCCCCCCCCCC | 45.98 | 26074081 | |
403 | Phosphorylation | APDDRTRTPLEPSNC CCCCCCCCCCCCCCC | 31.45 | 26074081 | |
408 | Phosphorylation | TRTPLEPSNCWSDLD CCCCCCCCCCCCCCC | 34.93 | 26074081 | |
412 | Phosphorylation | LEPSNCWSDLDGGNH CCCCCCCCCCCCCCC | 30.42 | 26074081 | |
451 | Phosphorylation | GHSDDTVYHDDKCMV CCCCCCCCCCCEEEE | 11.13 | - | |
466 | Phosphorylation | EVPQELETSTGHSLE ECCCHHHHCCCCCHH | 44.18 | 25159151 | |
467 | Phosphorylation | VPQELETSTGHSLEK CCCHHHHCCCCCHHH | 24.02 | 25159151 | |
468 | Phosphorylation | PQELETSTGHSLEKE CCHHHHCCCCCHHHH | 46.46 | 25159151 | |
471 | Phosphorylation | LETSTGHSLEKEFTN HHHCCCCCHHHHHCC | 39.30 | 25159151 | |
477 | O-linked_Glycosylation | HSLEKEFTNQEAAEP CCHHHHHCCCCCCCC | 36.76 | 23301498 | |
491 | Phosphorylation | PKEVPAHSTEVGRDH CCCCCCCCCCCCCCC | 28.50 | 25627689 | |
497 (in isoform 2) | Phosphorylation | - | 42.93 | - | |
506 | Phosphorylation | NEEEGEETGLRDEKP CHHHCCCCCCCCCCC | 36.89 | 26074081 | |
516 | Phosphorylation | RDEKPIKTEVPGSPA CCCCCCEEECCCCCC | 42.82 | 23927012 | |
521 | Phosphorylation | IKTEVPGSPAGTEGN CEEECCCCCCCCCCC | 12.90 | 28355574 | |
525 | Phosphorylation | VPGSPAGTEGNCQEA CCCCCCCCCCCCCCC | 42.71 | 23927012 | |
531 (in isoform 2) | Phosphorylation | - | 50.85 | 21406692 | |
533 | Phosphorylation | EGNCQEATGPSTVDT CCCCCCCCCCCCCCC | 49.20 | 25159151 | |
536 | Phosphorylation | CQEATGPSTVDTQNE CCCCCCCCCCCCCCC | 42.27 | 22199227 | |
537 | Phosphorylation | QEATGPSTVDTQNEP CCCCCCCCCCCCCCC | 26.07 | 21815630 | |
540 | Phosphorylation | TGPSTVDTQNEPLDM CCCCCCCCCCCCCCC | 29.02 | 22199227 | |
540 (in isoform 2) | Phosphorylation | - | 29.02 | - | |
541 (in isoform 2) | Phosphorylation | - | 48.07 | - | |
555 | Phosphorylation | KEPDEEKSDQQGEAL CCCCHHHCHHHHHHH | 43.88 | 19664994 | |
557 (in isoform 2) | Phosphorylation | - | 61.34 | 24719451 | |
559 (in isoform 4) | Phosphorylation | - | 19.26 | - | |
563 (in isoform 2) | Phosphorylation | - | 53.98 | - | |
564 | Phosphorylation | QQGEALDSSQKKTKN HHHHHHHHHHHHHHC | 35.20 | 23401153 | |
565 | Phosphorylation | QGEALDSSQKKTKNK HHHHHHHHHHHHHCH | 45.76 | 25159151 | |
568 | Acetylation | ALDSSQKKTKNKKKK HHHHHHHHHHCHHHC | 58.03 | 130861 | |
570 | Acetylation | DSSQKKTKNKKKKNK HHHHHHHHCHHHCCC | 75.54 | 130863 | |
575 (in isoform 4) | Phosphorylation | - | 80.85 | - | |
578 (in isoform 4) | Phosphorylation | - | 74.87 | - | |
581 | Phosphorylation | KKNKKKKSPVPVETL HCCCCCCCCCCHHHH | 39.75 | 25159151 | |
587 | Phosphorylation | KSPVPVETLKDVKKE CCCCCHHHHHHHHHH | 39.06 | 22199227 | |
589 | Ubiquitination | PVPVETLKDVKKELT CCCHHHHHHHHHHHH | 68.82 | - | |
592 | Acetylation | VETLKDVKKELTYQN HHHHHHHHHHHHCCC | 51.14 | 25953088 | |
593 | Ubiquitination | ETLKDVKKELTYQNT HHHHHHHHHHHCCCC | 58.78 | - | |
594 (in isoform 2) | Phosphorylation | - | 40.40 | 24719451 | |
596 | Phosphorylation | KDVKKELTYQNTDLS HHHHHHHHCCCCCHH | 24.93 | 26356563 | |
597 | Phosphorylation | DVKKELTYQNTDLSE HHHHHHHCCCCCHHH | 16.64 | 25159151 | |
600 | Phosphorylation | KELTYQNTDLSEIKE HHHHCCCCCHHHHHH | 23.85 | 26356563 | |
603 | Phosphorylation | TYQNTDLSEIKEEEQ HCCCCCHHHHHHHHH | 39.83 | 21815630 | |
606 | Sumoylation | NTDLSEIKEEEQVKS CCCHHHHHHHHHHCC | 55.83 | 28112733 | |
606 | Ubiquitination | NTDLSEIKEEEQVKS CCCHHHHHHHHHHCC | 55.83 | - | |
613 | Phosphorylation | KEEEQVKSTDRKSAV HHHHHHCCCCHHHHH | 36.36 | 23403867 | |
614 | Phosphorylation | EEEQVKSTDRKSAVE HHHHHCCCCHHHHHH | 33.82 | 23403867 | |
614 (in isoform 2) | Phosphorylation | - | 33.82 | 24719451 | |
618 | Phosphorylation | VKSTDRKSAVEAQNE HCCCCHHHHHHHHHH | 38.14 | 29255136 | |
627 | Phosphorylation | VEAQNEVTENPKQKI HHHHHHHCCCHHHHH | 24.70 | 27251275 | |
633 | Ubiquitination | VTENPKQKIAAESSE HCCCHHHHHHHHCCC | 40.20 | - | |
634 (in isoform 4) | Phosphorylation | - | 3.99 | 22199227 | |
638 | Phosphorylation | KQKIAAESSENVDCP HHHHHHHCCCCCCCC | 37.92 | 30278072 | |
639 | Phosphorylation | QKIAAESSENVDCPE HHHHHHCCCCCCCCC | 25.37 | 30278072 | |
644 | Glutathionylation | ESSENVDCPENPKIK HCCCCCCCCCCCCCE | 3.87 | 22555962 | |
649 | Ubiquitination | VDCPENPKIKLDGKL CCCCCCCCCEECCCC | 65.14 | - | |
652 (in isoform 2) | Phosphorylation | - | 13.79 | - | |
663 (in isoform 2) | Phosphorylation | - | 6.92 | - | |
665 | Phosphorylation | QEGDDVQTAAEEVLA CCCCHHHHHHHHHHC | 27.90 | 27499020 | |
676 | Phosphorylation | EVLADGDTLDFEDDT HHHCCCCEECCCCCC | 33.48 | 18669648 | |
687 | Phosphorylation | EDDTVQSSGPRAGGE CCCCCCCCCCCCCCC | 35.41 | 18669648 | |
687 (in isoform 2) | Phosphorylation | - | 35.41 | 21406692 | |
689 (in isoform 2) | Phosphorylation | - | 25.54 | 21406692 | |
690 (in isoform 2) | Phosphorylation | - | 49.76 | 24719451 | |
709 (in isoform 2) | Phosphorylation | - | 33.71 | 24719451 | |
711 | Phosphorylation | NAKIDGATQSSPAEP CCCCCCCCCCCCCCC | 34.22 | 23927012 | |
711 (in isoform 2) | Phosphorylation | - | 34.22 | 24719451 | |
713 | Phosphorylation | KIDGATQSSPAEPKS CCCCCCCCCCCCCCC | 33.65 | 29255136 | |
714 | Phosphorylation | IDGATQSSPAEPKSE CCCCCCCCCCCCCCC | 20.50 | 19664994 | |
720 | Phosphorylation | SSPAEPKSEDADRCT CCCCCCCCCCCCCCC | 51.96 | 23401153 | |
725 | Methylation | PKSEDADRCTLPEHE CCCCCCCCCCCCCCC | 19.62 | 115482327 | |
726 | Carbamidation | KSEDADRCTLPEHES CCCCCCCCCCCCCCC | 4.76 | 17322306 | |
727 | Phosphorylation | SEDADRCTLPEHESP CCCCCCCCCCCCCCC | 46.36 | 30266825 | |
733 | Phosphorylation | CTLPEHESPSQDISD CCCCCCCCCCCCHHH | 31.58 | 29255136 | |
735 | Phosphorylation | LPEHESPSQDISDAC CCCCCCCCCCHHHHH | 50.17 | 29255136 | |
739 | Phosphorylation | ESPSQDISDACEAES CCCCCCHHHHHHHHH | 27.69 | 30266825 | |
742 | Carbamidation | SQDISDACEAESTER CCCHHHHHHHHHCCC | 6.46 | 17322306 | |
742 (in isoform 2) | Phosphorylation | - | 6.46 | 24719451 | |
744 (in isoform 2) | Phosphorylation | - | 18.87 | 24719451 | |
746 | Phosphorylation | SDACEAESTERCEMS HHHHHHHHCCCCCCC | 42.49 | 23927012 | |
747 | Phosphorylation | DACEAESTERCEMSE HHHHHHHCCCCCCCC | 20.96 | 24702127 | |
753 | Phosphorylation | STERCEMSEHPSQTV HCCCCCCCCCHHHHH | 15.51 | - | |
757 | Phosphorylation | CEMSEHPSQTVRKAL CCCCCCHHHHHHHHH | 40.15 | 20068231 | |
759 | Phosphorylation | MSEHPSQTVRKALDS CCCCHHHHHHHHHHC | 26.98 | 20068231 | |
762 | Ubiquitination | HPSQTVRKALDSNSL CHHHHHHHHHHCCCC | 49.30 | - | |
766 | Phosphorylation | TVRKALDSNSLENDD HHHHHHHCCCCCCCC | 29.21 | 29255136 | |
768 | Phosphorylation | RKALDSNSLENDDLS HHHHHCCCCCCCCCC | 40.80 | 29255136 | |
775 | Phosphorylation | SLENDDLSAPGREPG CCCCCCCCCCCCCCC | 39.14 | 23927012 | |
788 | Phosphorylation | PGHFNPESREDTRGG CCCCCCCCCCCCCCC | 42.08 | 20873877 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRRF1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRRF1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRRF1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FLII_HUMAN | FLII | physical | 9525888 | |
FLII_HUMAN | FLII | physical | 19265123 | |
CN166_HUMAN | C14orf166 | physical | 22863883 | |
RTCB_HUMAN | RTCB | physical | 22863883 | |
DDX1_HUMAN | DDX1 | physical | 22863883 | |
DHX9_HUMAN | DHX9 | physical | 22863883 | |
SYEP_HUMAN | EPRS | physical | 22863883 | |
FLII_HUMAN | FLII | physical | 22863883 | |
MRE11_HUMAN | MRE11A | physical | 22863883 | |
PRKDC_HUMAN | PRKDC | physical | 22863883 | |
RFC2_HUMAN | RFC2 | physical | 22863883 | |
MED4_HUMAN | MED4 | physical | 25416956 | |
CEP44_HUMAN | CEP44 | physical | 25416956 | |
TMOD3_HUMAN | TMOD3 | physical | 28514442 | |
TMOD1_HUMAN | TMOD1 | physical | 28514442 | |
FLII_HUMAN | FLII | physical | 28514442 | |
TFR2_HUMAN | TFR2 | physical | 28514442 | |
CCNB1_HUMAN | CCNB1 | physical | 28514442 | |
TCAL2_HUMAN | TCEAL2 | physical | 28514442 | |
MCTS1_HUMAN | MCTS1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115; SER-120 ANDSER-618, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116; SER-638; THR-711;SER-713 AND SER-714, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-120; SER-124;SER-581; SER-618; THR-676; SER-714 AND SER-733, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-714, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-733, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-521 AND SER-714, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-295, AND MASSSPECTROMETRY. |